home.social

Search

1000 results for “ChristosQr”

  1. @smxi @ChristosArgyrop Of course, there’s a #PerlCritic policy to slap you on the wrist if you’re tempted to do such a rude thing as automatically export into a caller’s namespace: metacpan.org/pod/Perl::Critic:

  2. @randomatic @[email protected] @HaplogroupNews @[email protected] A previous employer of mine used re::engine::RE2 for many things, because a) you can cap the memory usage to avoid #DoS attacks, and b) the lead developer was all about premature optimization. metacpan.org/pod/re::engine::R

    But you can’t use the /x flag for better readability, and we ran into some nasty #Unicode bugs and had to fall back to regular Perl #RegExps in those cases.

  3. @Bneuen @Kidney_boy @ChristosArgyrop so you don’t think highly of Sean Barbour’s point that reducing proteinuria with RASi + Flozin = you might miss some patients who may benefit with steroids?

    #NephMadness

  4. Also somewhat surprising: risk of infection related badness in lupus = risk of infection related badness in diabetic kidney disease! Possibly underscoring that (some of us) underestimate the infection related hazards when DM + CKD exist Any other comments @[email protected] #NephSky

  5. Is this a symptom of when reality pierces the motivated and reasoned veil of ignorance?

    h/t @ChristosArgyrop

    #MotivatedReasoning #journalism #COVID19

  6. Subgroup analysis from the #empagliflozin #RECOVERY trial

    Mostly chance for the couple of subgroups I guess? (Less severe disease cc @ChristosArgyrop )

    3/

  7. whoah whoah whoah.....non-IS in IgAN...just as all the IS trials are dropping like TESTING, NEFIGARD and more to come?

    What do you say @Bneuen and @ChristosArgyrop - team #flozinator or team #immunosuppression?

    I think flozins have had their time in the spotlight - time to let IS come ahead?

    So #BlueRibbonFail #NephMadness

  8. whoah whoah whoah.....non-IS in IgAN...just as all the IS trials are dropping like TESTING, NEFIGARD and more to come?

    What do you say @Bneuen and @ChristosArgyrop - team #flozinator or team #immunosuppression?

    I think flozins have had their time in the spotlight - time to let IS come ahead?

    So #BlueRibbonFail #NephMadness

  9. whoah whoah whoah.....non-IS in IgAN...just as all the IS trials are dropping like TESTING, NEFIGARD and more to come?

    What do you say @Bneuen and @ChristosArgyrop - team #flozinator or team #immunosuppression?

    I think flozins have had their time in the spotlight - time to let IS come ahead?

    So #BlueRibbonFail #NephMadness

  10. whoah whoah whoah.....non-IS in IgAN...just as all the IS trials are dropping like TESTING, NEFIGARD and more to come?

    What do you say @Bneuen and @ChristosArgyrop - team #flozinator or team #immunosuppression?

    I think flozins have had their time in the spotlight - time to let IS come ahead?

    So #BlueRibbonFail #NephMadness

  11. whoah whoah whoah.....non-IS in IgAN...just as all the IS trials are dropping like TESTING, NEFIGARD and more to come?

    What do you say @Bneuen and @ChristosArgyrop - team #flozinator or team #immunosuppression?

    I think flozins have had their time in the spotlight - time to let IS come ahead?

    So #BlueRibbonFail #NephMadness

  12. Should you hesitate to start #Flozins higher when sugars too high? Here’s that idea debunked in a propensity score matched analysis in JAMA IM

    jamanetwork.com/journals/jamai

    Efficacy maintained and AEs consistent across HgbA1c strata (and all favouring Flozins except genital infxn)

    Any comments @mike_johansen @ChristosArgyrop @Bneuen ?

  13. Sick day rules and #Flozins

    Detailed contrarian review and good discussion of #SGLT2i use during hospitalization pubmed.ncbi.nlm.nih.gov/358013 (gated)

    Given the benefit: the authors suggest continuing Flozins and doing daily glucose + ketones testing

    @ChristosArgyrop & @mike_johansen for thoughts?
    See their algorithm:

  14. Sick day rules and #Flozins

    Detailed contrarian review and good discussion of #SGLT2i use during hospitalization pubmed.ncbi.nlm.nih.gov/358013 (gated)

    Given the benefit: the authors suggest continuing Flozins and doing daily glucose + ketones testing

    @ChristosArgyrop & @mike_johansen for thoughts?
    See their algorithm:

  15. Sick day rules and #Flozins

    Detailed contrarian review and good discussion of #SGLT2i use during hospitalization pubmed.ncbi.nlm.nih.gov/358013 (gated)

    Given the benefit: the authors suggest continuing Flozins and doing daily glucose + ketones testing

    @ChristosArgyrop & @mike_johansen for thoughts?
    See their algorithm:

  16. Sick day rules and #Flozins

    Detailed contrarian review and good discussion of #SGLT2i use during hospitalization pubmed.ncbi.nlm.nih.gov/358013 (gated)

    Given the benefit: the authors suggest continuing Flozins and doing daily glucose + ketones testing

    @ChristosArgyrop & @mike_johansen for thoughts?
    See their algorithm:

  17. Sick day rules and #Flozins

    Detailed contrarian review and good discussion of #SGLT2i use during hospitalization pubmed.ncbi.nlm.nih.gov/358013 (gated)

    Given the benefit: the authors suggest continuing Flozins and doing daily glucose + ketones testing

    @ChristosArgyrop & @mike_johansen for thoughts?
    See their algorithm:

  18. Recently, I saw a nice infographic showing the existing therapeutic interventions that have been proven to lower hard endpoint in #dialysis.
    Amongst them were FishOil and HDF - but I fail to remember who posted it and thus am unable find this beautiful infographic!

    Can you help the desperate me, @hswapnil @ChristosArgyrop
    @pwoywodt.bsky.social

    #nephrology